REGENXBIO Inc. (RGNX)
NASDAQ·Healthcare·Biotechnology
$9.68
+0.83%
Mkt Cap $503.01M
Analyst Ratings
Buy
11
Hold
1
Sell
0
Price Target (22 analysts)
$22.50
Range $12.00 – $45.00
Implied Upside
+132.4%
Consensus $22.50 vs current $9.68
NASDAQ·Healthcare·Biotechnology
$9.68
+0.83%
Mkt Cap $503.01M
Buy
11
Hold
1
Sell
0
Price Target (22 analysts)
$22.50
Range $12.00 – $45.00
+132.4%
Consensus $22.50 vs current $9.68